$Rig's Platinum Penny Alerts

[TORPEDO]

MILV


Projected short-term $.12
https://wwws.ameritrade.com/cgi-bin/apps/Main


AwesomePennyStocks email 10/27/11, 6:36 PM

Hi Everyone,

For our new subscribers, Welcome!

MILV now becomes our official new pick. It is such a promising company that it's already gone up 45% today but rest assured we see a massive upside that remains still.

Just last year it had touched nearly 30 cents. We think that with the way things are going and with what is happening over at the company 30 cents or possibly more can be realistic right now.

As a matter of fact our last pick jumped from 10 cents to over $1 for a total of more than 1000% gains.

If that were to repeat itself again on this new pick we would be seeing it flirt with the 40 cent range.

Thinking logically there must be a reason why everyone was agressively buying today. They were buying as much as they could which resulted in total record breaking volume of 257,000,000 shares traded.

We think that the news released a few hours could be helping fuel this great run as it leaves us wondering what MILV's relationship is with the FDA and if they are about to be seeking or getting FDA approval on their new cold and flu medicine. A medicine which they suggest could generate $100 million in revenue for the company while possibly capturing 3% of the US market for that category.

Nature's Bioceuticals develops and acquires the rights to natural medicine formulas that are geared toward treating specific medical conditions. These medicines are all-natural and derived from botanicals and mineral bases.

Nature's Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today's prescribed drugs.

Nature's line of Natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA."

MILV could become an important winner for our members. We rarely feature bioceutical companies, and when we do they typically do very well for everyone.

We really feel like MILV could continue running up high. If you miss out you may regret it in a few days.

You can visit the company's website at NaturesBioceuticals dot com

Happy Trading!

Your AwesomePennyStocks Editor.